Showing results (381-390 of 549) with videos related to
Sort By:
Pageof 55
Science Translational Medicine|January 13, 2017
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressionsMarc Damelin, Alexander Bankovich, Jeffrey Bernstein, et al.Circulation|February 21, 2023
Multiancestry Genome-Wide Association Study of Aortic Stenosis Identifies Multiple Novel Loci in the Million Veteran ProgramAeron M Small, Gina M Peloso, Jason Linefsky, et al.Chemistry & Biology|February 27, 2013
Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugatesPavel Strop, Shu-Hui Liu, Magdalena Dorywalska, et al.Circulation. Genomic and Precision Medicine|November 14, 2022
Fibromuscular Dysplasia and Abdominal Aortic Aneurysms Are Dimorphic Sex-Specific Diseases With Shared Complex Genetic ArchitectureAlexander E Katz, Min-Lee Yang, Michael G Levin, et al.Hypertension (Dallas, Tex. : 1979)|June 21, 2021
Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran ProgramElvis A Akwo, Cassianne Robinson-Cohen, Cecilia P Chung, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 12, 2013
Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: the CKDGen consortiumMatthias Olden, Alexander Teumer, Murielle Bochud, et al.Journal of Medicinal Chemistry|January 2, 2010
Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition modelsChristopher J O'Donnell, Bruce N Rogers, Brian S Bronk, et al.Journal of Medicinal Chemistry|April 24, 2015
The discovery and characterization of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiator N-{(3S,4S)-4-[4-(5-cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242)Christopher L Shaffer, Nandini C Patel, Jacob Schwarz, et al.Epidemiology (Cambridge, Mass.)|May 3, 2019
Development of the Initial Surveys for the All of Us Research ProgramRobert M Cronin, Rebecca N Jerome, Brandy Mapes, et al.American Journal of Human Genetics|April 4, 2020
Genotyping Array Design and Data Quality Control in the Million Veteran ProgramHaley Hunter-Zinck, Yunling Shi, Man Li, et al.Pageof 55